Brief: Waverley Pharma Announces Filing Of Two Abbreviated NDAs In U.S.
27/06/2018 13:39
June 27 (Reuters) - Waverley Pharma Inc WAVE.V :
* WAVERLEY PHARMA ANNOUNCES FILING OF TWO ABBREVIATED NEW
DRUG
APPLICATIONS IN THE UNITED STATES
* WAVERLEY PHARMA INC - CO'S UNIT HAS SUBMITTED ANDAS WITH
UNITED
STATES FOOD AND DRUG ADMINISTRATION FOR TWO HIGH VALUE
ANTI-CANCER GENERIC DRUGS
Source text for Eikon: ID:nCNWV38vTa
Further company coverage: WAVE.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Waverley Pharma
See all newsBrief: Waverley Pharma Announces Chief Financial Officer Change
Brief: Waverley Pharma Acquires Us Based Pharmacy
Brief: Waverley Pharma Business Update
Brief: Waverley Pharma Provides Update On Its Parp-1 Inhibitor Program
Brief: Waverley Pharma - Co's Unit Awarded Exclusive Distribution Rights For Two Strengths Of Pemetrexed By NHS England